Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST BREAST CANCER CONTENT
Trials Demonstrate First-Line Role of Sacituzumab in Metastatic TNBC
Oncologists Discuss Optimizing the Use of Elacestrant in Breast Cancer
Selecting Second-Line Treatment in HR+, HER2-Low Breast Cancer
Selecting Cytotoxic Partner For Pembrolizumab in PD-L1+ TNBC
Dato-DXd Shows Tolerability Vs Chemo in HER2- Metastatic Breast Cancer
Reviewing Ribociclib's Role in HR+, HER2- Early Breast Cancer
Applying NCCN Guidelines for Pre- and Post-Menopausal Breast Cancer
Treatment With ADCs Advances in Endocrine-Refractory Breast Cancer
CASE-BASED ROUNDTABLES
Advertisement
Advertisement
